down arrow

Rallybio Corp.

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: US75120L1008
USD
0.78
0.06 (8.34%)

Dec 18

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.730.80

52 Week

0.221.08
Valuation
Technical
Day's Volume

CASH

291.29 k

Shareholding (Mar 2025)

FII

8.04%

Held by 27 FIIs

DII

24.62%

Held by 17 DIIs

Promoter

53.97%

How big is Rallybio Corp.?

22-Jun-2025

As of Jun 18, Rallybio Corp. has a market capitalization of 14.07 million, with net sales of 0.85 million and a net loss of 48.19 million over the latest four quarters. Shareholder's funds are 61.65 million, and total assets amount to 68.11 million.

As of Jun 18, Rallybio Corp. has a market capitalization of 14.07 million, classifying it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.85 million for the latest four quarters, while the net profit for the same period was a loss of 48.19 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds of 61.65 million and total assets amounting to 68.11 million.

Read More

What does Rallybio Corp. do?

22-Jun-2025

Rallybio Corp. is a micro-cap company in the miscellaneous industry, reporting net sales of $0 million and a net loss of $9 million as of March 2025, with a market cap of $14.07 million. Key metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -89.11%.

Overview: <BR>Rallybio Corp. operates in the miscellaneous industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -9 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 14.07 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.01 <BR>Return on Equity: -89.11% <BR>Price to Book: 0.26<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is Rallybio Corp. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, Rallybio Corp. is in a mildly bearish trend, with daily moving averages and weekly RSI indicating bearish momentum, despite some mild bullish signals from the MACD and Bollinger Bands, and it has underperformed the S&P 500 with a year-to-date return of -37.58%.

As of 8 September 2025, the technical trend for Rallybio Corp. has changed from sideways to mildly bearish. The current stance is bearish, primarily driven by the daily moving averages indicating a mildly bearish position and the weekly RSI showing bearish momentum. Although the weekly MACD and Bollinger Bands suggest mild bullishness, they are overshadowed by the overall bearish signals from the daily indicators. The stock has underperformed significantly against the S&P 500, with a year-to-date return of -37.58% compared to the S&P 500's 12.22%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 25 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.99

stock-summary
Return on Equity

-86.92%

stock-summary
Price to Book

0.54

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-10 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
29.81%
0%
29.81%
6 Months
138.52%
0%
138.52%
1 Year
-20.32%
0%
-20.32%
2 Years
-73.18%
0%
-73.18%
3 Years
-86.7%
0%
-86.7%
4 Years
-92.44%
0%
-92.44%
5 Years
0%
0%
0.0%

Rallybio Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-46.54%
EBIT Growth (5y)
-259.43%
EBIT to Interest (avg)
-53.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.01
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
93.30%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.30
EV to EBIT
0.75
EV to EBITDA
0.76
EV to Capital Employed
37.94
EV to Sales
-37.94
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5037.90%
ROE (Latest)
-89.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 19 Schemes (13.37%)

Foreign Institutions

Held by 27 Foreign Institutions (8.04%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -33.33% vs 0.00% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 40.12% vs 12.90% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.30",
          "val2": "-17.00",
          "chgp": "51.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.70",
          "val2": "-16.20",
          "chgp": "40.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-39,419.80%",
          "val2": "-56,973.20%",
          "chgp": "1,755.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 22.52% vs -11.84% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-60.40",
          "val2": "-78.80",
          "chgp": "23.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-57.80",
          "val2": "-74.60",
          "chgp": "22.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-95,119.50%",
          "val2": "0.00%",
          "chgp": "-9,511.95%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.20
0.30
-33.33%
Operating Profit (PBDIT) excl Other Income
-8.30
-17.00
51.18%
Interest
0.00
0.00
Exceptional Items
-1.70
0.00
Consolidate Net Profit
-9.70
-16.20
40.12%
Operating Profit Margin (Excl OI)
-39,419.80%
-56,973.20%
1,755.34%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -33.33% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 40.12% vs 12.90% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.60
0.00
Operating Profit (PBDIT) excl Other Income
-60.40
-78.80
23.35%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-57.80
-74.60
22.52%
Operating Profit Margin (Excl OI)
-95,119.50%
0.00%
-9,511.95%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 22.52% vs -11.84% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Rallybio Corp. stock-summary
stock-summary
Rallybio Corp.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."